Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Washington University in St. Louis
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4231968797
